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Introduction {#sec1.1}
------------

While the epigenetics field identified important roles for DNA and histone modifications, epitranscriptomics has only begun to characterize and legitimize the importance of RNA modifications in all three kingdoms of life. With respect to eukaryotes, RNA modifications play a role in regulating transfer RNA (tRNA) and ribosomal RNA (rRNA) structure and function, messenger RNA (mRNA) translation efficiency and stability, microRNA maturation, cell differentiation, and innate sensing pathways of pathogens, to name a few ([@bib27]). The most abundantly modified RNAs in eukaryotes are those present on cellular rRNAs and tRNAs, which regulate RNA structure and function ([@bib6], [@bib42], [@bib58]). Several modifications have been identified in mRNAs and non-coding RNAs (ncRNAs) such as N^1^-methyladenosine (m^1^A), N^6^-methyladenosine (m^6^A), 5-methylcytidine (m^5^C), inosine (I), pseudouridine (Ψ), and the 5′ cap modifications *N* ^6^,2-O-dimethyladenosine (m^6^A~m~) and 2′-O-methylation (2′-O-me). Methods to detect such modifications and their interactions with RNA binding proteins are summarized in a recent comprehensive review ([@bib15]). Recent studies in the viral epitranscriptomics field have established an equally important role for these chemical modifications during viral infection. For example, m^6^A-modifications can positively affect RNA replication or negatively affect RNA assembly, dependent on the lifestyle of the virus. Thus, m^6^A-modifications can have pro- or antiviral functions and, thus, offer new potential targets for antiviral intervention.

These advances in epitranscriptomics have been powered by improvements of several techniques to study RNA modifications and RNA-binding proteins. First, the refinement of high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) has led to greater confidence in the detection of RNA modifications and their abundances. Further, transcriptome sequencing has been paired with three classic techniques to identify specific modifications within unique transcripts: (a) surveying altered base-pairing properties at the site of modification; (b) identification of truncated products caused by reverse transcription at the modified site; and (c) antibody-based isolation and enrichment of RNAs with specific modifications. Using a combination of these techniques has been instrumental in validating chemical modifications present in host and viral RNAs. For further information about the usefulness and limitations of each of these techniques, please refer to the excellent reviews by [@bib53] and [@bib28].

In this review, we focus on the recent work describing how adenosine modifications, m^6^A, m^6^A~m~, 2′-O-me, and A-to-I editing ([Figure 1](#fig1){ref-type="fig"} ) play a role in the life cycle of certain RNA viruses. We discuss the role of these modifications with respect to viral cap structures, viral replication, innate sensing pathways, and modulation of the innate immune response. The content presented here will give a current understanding of how a handful of different viral RNAs are modified, how the changes in RNA alter the virus life cycle, and what remains to be clarified in the field.Figure 1Adenosine Modifications and the Respective Enzymes that Facilitate These Chemical Modifications*N*^6^-methyladenosine and *N*^6^,2-O-dimethyladenosine are reversible RNA modifications, while inosine and 2′-O-methyladenosine seem to be irreversible. Of the modifications listed, only 2′-O-methyltransferases are encoded by viral genes (WNV, West Nile virus; DV, dengue virus; H-CoV, human coronavirus), further supporting the important role for this modification in modulating viral sensing by innate immune pathways.

Roles for N^6^-Methyladenosine Modification in the Life Cycle of Retroviridae and Flaviviridae {#sec1.2}
----------------------------------------------------------------------------------------------

It has been known for a long time that RNAs transcribed both in DNA virus- and RNA virus-infected cells can be modified on adenosine residues. For example, Lavi and Shatkin reported that RNAs from simian virus 40, a small DNA virus, are modified on adenosines in infected cells ([@bib26]). Krug et al. provided an example that the viral RNA genomes of influenza virus are modified as well ([@bib25]). However, it was not until 1985 when Kane and Beemon reported that specific adenosines were methylated in viral RNAs in cells infected with Rous sarcoma virus ([@bib20]). More recently, m^6^A has been the focus of intense study in elucidating the role of this RNA modification in viral epitranscriptomics ([@bib11], [@bib23]).

### The Machinery---Writers, Erasers, Readers---That Performs and Modulates m^6^A Modifications {#sec1.2.1}

The identification of methyltransferases and demethylases demonstrated that m^6^A modification was reversible and sensitive to external signals. The methyltransferase "writer" complex consists of Methyltransferase Like 3 (METTL3) ([@bib4]), Methyltransferase Like 14 (METTL14) ([@bib34]), KIAA1429 ([@bib54]), and Wilms' Tumor 1-Associating Protein (WTAP) ([@bib48]) ([Figure 1](#fig1){ref-type="fig"}). WTAP aids METTL3/METTL14 to interact with mRNAs in the nucleus to improve m^6^A modification efficiency ([@bib34], [@bib48]). The importance of each of these factors has been validated using depletion and gene knockout approaches. Depletion of writers METTL3, METTL14, or WTAP reduces m^6^A abundances by approximately 2-, 2.5-, and 6.5-fold in eukaryotic cells, respectively ([@bib34], [@bib54]). Although not as dramatic as WTAP depletion, depletion of KIAA1429 in human cells results in a 4-fold decrease of m^6^A abundance ([@bib54]). Recent structural studies have demonstrated that METTL3 is the catalytic subunit of the writer complex, while METTL14 plays a role in complex stability and RNA recruitment ([@bib57]). Most recently, RNA-binding motif protein 15 (RBM15) and its paralog RBM15B have been identified as members of the m^6^A writer complex that recruits the METTL3/14 protein complex to long ncRNAs ([@bib44]). Future studies are needed to define the role, if any, of RBM15 and RBM15B in the context of other RNA species, including viral RNAs.

Reversal of m^6^A is performed by at least two demethylase "erasers" that have been identified in mammalian cells. Fat mass and obesity-associated protein (FTO) is associated with human body weight regulation ([@bib18]), while ALKBH5 is associated with fertility in mice ([@bib68]) ([Figure 1](#fig1){ref-type="fig"}). The reversibility of the m^6^A modification suggests a dynamic role for the modification in controlling the fate of modified RNAs. Indeed, m^6^A modifications have been reported to modulate eukaryotic translation efficiency ([@bib33], [@bib65]), cap-independent translation ([@bib40]), mRNA stability ([@bib54]), RNA splicing ([@bib8]), and miRNA biogenesis ([@bib1]). More globally, m^6^A abundance in specific RNAs correlates with their functioning in cellular reprogramming ([@bib5]), heat shock response ([@bib69]), circadian cycle ([@bib10]), cell development ([@bib48]), and fertility ([@bib68]). Most likely, the function of m^6^A-containing RNAs is determined by "readers," including the YTH domain-containing family proteins (YTHDF1--YTHDF3), each of which recognize and bind m^6^A moieties in RNAs with their conserved carboxy-terminal YTH motif ([@bib39]).

In addition, it is known that m^6^A can alter local RNA structures, for example, by destabilizing RNA helices. Thus, m^6^A can affect RNA stability or possibly RNA localization. Additionally, heterogeneous ribonucleoproteins (hnRNP) have recently been shown to interact with m^6^A-modified RNA. The presence of m^6^A modifies local RNA structure, which promotes the nuclear protein hnRNP C to bind to this region and to modulate pre-mRNA processing ([@bib35]). Further, hnRNP A2B1 interacts with m^6^A to similarly promote micoRNA processing and alternative splicing ([@bib1]). The nuclear localization of these RNA-binding proteins suggests a role in the life cycle of viruses that replicate their genomes in the nucleus, such as influenza virus.

### Roles for m^6^A in the Life Cycle of Human Immunodeficiency Virus {#sec1.2.2}

Three recent publications revealed some common and some controversial roles for m^6^A modifications in the HIV life cycle ([@bib30], [@bib22], [@bib62]) ([Figure 2](#fig2){ref-type="fig"} ). A common observation is that writers METTL3/METTL14 promote HIV replication, while erasers ALKBH5 and FTO suppress it ([@bib30], [@bib62]) ([Figure 2](#fig2){ref-type="fig"}). In addition, the compound 3-deazaadenosine, which blocks m^6^A methylation, has been shown to inhibit the growth of HIV at concentrations that did not affect cell viability ([@bib22]). However, it is not known yet whether this inhibitor has additional unspecific effects. More directly, mutations of identified m^6^A residues reduced viral RNA abundances and viral titers ([@bib22]). Using a CD4^+^ T cell model, Lichinichi et al. reported that HIV infection enhances m^6^A modifications of both viral and host RNAs, and depletion of the m^6^A writers and erasers decreased and increased HIV infection, respectively ([@bib30]). Interestingly, several host mRNAs are modified at m^6^A during HIV infection such as *TRAF2*, *PABPC3*, and *ETS2*, all of which are known to have pro-viral functions. It will be interesting to identify and to mutate the modified adenosine residues in these mRNAs to examine whether they exert their pro-viral functions at the level of mRNA stability or mRNA translation. Overall, there is agreement that m^6^A in HIV RNA modulates viral gene expression.Figure 2Three Current Models for m^6^A-Mediated Regulation of the HIV-1 Life Cycle(A) m^6^A enhances HIV virus production ([@bib30]). Stemloop II within the HIV Rev response element (RRE) is m^6^A methylated at two sites, which promotes the HIV-encoded RNA binding protein, Rev, to bind to the RRE and enhance RNA nuclear export into the cytoplasm. Depletion of the methyltransferases METTL3/14 suppressed HIV-1 RNA export and viral replication, suggesting that m^6^A modifications within the RRE are important for the HIV life cycle.(B) m^6^A enhances HIV RNA replication ([@bib22]). Like the model presented in (A), this second study confirmed that the presence of m^6^A enhances viral replication. Cellular m^6^A-modified HIV RNAs are bound by the reader YTHDF proteins, which promote HIV replication. Depletion of YTHDF proteins reduced viral RNA abundance and virus titers, as did mutating certain m^6^A-modified adenosine residues to guanines.(C) m^6^A enhances HIV mRNA translation, but m^6^A/YTHDF readers reduce HIV reverse transcription ([@bib62]). In contrast to the models presented in (A) and (B), m^6^A was found to enhance translation, but to suppress reverse transcription, suggesting a modular role in the HIV life cycle depending on the replication step. Depletion of METTL3/14 resulted in a reduction of viral protein expression, while the depletion of YTHDF proteins enhanced HIV reverse transcription.

The three reports disagree by what mechanisms m^6^A modulates HIV gene expression. First, the number and locations of m^6^A sites in the HIV RNA genome is controversial. [@bib22] identified m^6^A sites exclusively within the 3′ region of the RNA genome; in contrast, [@bib30] identified 14 m^6^A modifications throughout the entire HIV RNA genome, including 2 in the Rev responsive element (RRE), a structured region that is bound by the viral Rev protein ([Figure 2](#fig2){ref-type="fig"}). These modified residues modulate nuclear export of RRE-containing RNAs and enhance the binding of the viral Rev protein to the RRE ([Figure 2](#fig2){ref-type="fig"}). Curiously, 11 of the identified modified sites locate 5′ to the sites identified by [@bib22].

Why did mapping m^6^A residues yield such different results? Some obvious reasons could be the use of different viral strains, cell types, and reagents. Other differences between the authors' techniques could account for some of the observed differences. For example, the amount of RNA in the m^6^A-RNA immunoprecipitation and crosslinking-immunoprecipitation experiments likely play a role in the accuracy of the analysis. Furthermore, changes in the sensitivity of the bioinformatics pipeline could have large effects on output. In addition, different viral replication kinetics could also influence the dynamic behavior of readers, writers, and eraser proteins. One main difference between the m^6^A mapping strategy is that [@bib30] immunoprecipitated fragmented RNA with an antibody directed against m^6^A. In contrast, [@bib22] labeled viral RNA with 4-thiouridine and then crosslinked the m^6^A antibody to the full-length RNA. In addition, cell-based crosslinking of tagged YTHDF1--YTHDF3 reader proteins to viral RNA revealed very similar sites of crosslinking in both approaches, except that the YTHDF proteins could be crosslinked in addition to a region in the viral *nef* gene. Because accessibility of m^6^A antibodies to m^6^A sites could be different in fragmented versus full-length RNAs, these different approaches may yield different results should high-order RNA structures play a role in the antibody-assisted recognition of m^6^A residues. Crosslinking of YTHDF proteins to target RNAs before m^6^A analysis should thus minimize the potential artifact that distinct YTHDF interaction affinities occur at specific m^6^A sites in RNAs.

In addition, the effect of each YTHDF on HIV transcription and replication remains controversial. Kennedy et al. observe that YTHDF reader protein overexpression enhances HIV replication and HIV p24, p55, and Nef protein abundance, while Tirumuru et al. observe that overexpression of YTHDF proteins suppress reverse transcription and HIV replication ([@bib22], [@bib62]). Both studies utilized overexpression and depletion approaches using a similar VSV-pseudotyped HIV infection model. It is currently unclear what caused the large discrepancy between the two studies. Non-physiological overexpression or non-quantitative depletion of YTHDF reader proteins could reveal results that are not physiologically relevant. Because m^6^A modification is reversible, it is possible that distinct m^6^A residues are targeted by writers, erasers, and readers in a dynamic process that may be influenced by the growth state of the cell, or by cellular events that accompany HIV infection. A recent review has suggested that the presence of a Firefly luciferase reporter sequence in the HIV genome used by [@bib62] might bias the abundance of YTHDF and effects on HIV replication, because this non-viral RNA sequence can be heavily modified by m^6^A ([@bib23]).

In addition to the role of YTHDF proteins in regulating the HIV life cycle, hnRNP proteins might interact with HIV RNA in an m^6^A-dependent manner. hnRNP C has been shown to interact with m^6^A-modified RNAs, promoting pre-splicing events ([@bib35]). Previous studies have shown that other hnRNP proteins affect the HIV life cycle, including numerous hnRNP proteins that interact with the HIV Rev protein ([@bib14]). Thus, the binding of Rev to the m^6^A-containing RRE element present in HIV RNA ([@bib30]) could be modulated by hnRNP C.

### Roles for m^6^A in the Life Cycle of Hepatitis C Virus and Zika Virus {#sec1.2.3}

Until recently, there was little evidence that functional m^6^A methyltransferases operated outside of the nucleus. Recent studies with viruses that have exclusively cytoplasmic life cycles have demonstrated a broader role for the writer enzymes in the cytoplasm as well. Two recent studies describe the role of m^6^A modifications in regulating different members of *Flaviviridae*, whose gene expression takes place in the cytosol. To date, m^6^A analysis has been performed in cells infected with HCV, dengue virus (DV), West Nile virus (WNV), yellow fever virus (YFV), and three strains of Zika virus (ZV) ([@bib12], [@bib31]).

The regulation of HCV RNA by small microRNAs and by RNA structures has been widely appreciated. Liver-specific microRNA miR-122 is required for HCV replication and has been shown to bind at two sites at the 5′ end of the HCV genome to protect the viral RNA from degradation by host cell exoribonucleases ([@bib19]). Further, using *s*elective 2′-*h*ydroxyl *a*cylation analyzed by *p*rimer *e*xtension (SHAPE), a number of structures and ribonucleotide interactions have been shown to play an important role in regulating the virus life cycle, as mutating these sites led to the inhibition or enhancement of viral replication ([@bib38], [@bib49]). An additional level of regulation at the RNA level has been recently provided by Stacy Horner's laboratory. Gokhale and colleagues identified 19 sites of m^6^A enrichment within the HCV RNA genome, including sites spanning the 5′ UTR, the *core* gene, as well as other genes within the HCV genome ([@bib12]). m^6^A present in 5′ UTRs has been shown to enhance mRNA translation in a cap-independent manner ([@bib40]). This observation may explain how viruses, such as HCV, utilize cap-independent mechanisms to initiate the production of viral proteins. HCV contains an internal ribosome entry site (IRES) that directly binds the 40S subunit of the ribosome without the use of the cap binding protein complex eIF4F ([@bib24], [@bib46]). Although Gokhale et al. did not detect a defect in HCV translation in the absence of m^6^A writers ([@bib12]), other viral genomes that can be translated when eIF4F abundance is low could be affected by the presence of m^6^A.

The importance of m^6^A modifications in the HCV viral life cycle was demonstrated by siRNA-mediated depletion of the methyltransferases METTL3, METTL14, and FTO, which showed that the methyl writers METTL3/14 negatively regulate HCV protein expression, while the methyl eraser FTO enhanced viral protein expression ([@bib12]) ([Figure 3](#fig3){ref-type="fig"} ). In addition, the methyl YTHDF readers have been implicated in modulating viral assembly. YTHDF1--YTHDF3 reader proteins colocalize with HCV RNA to lipid droplets, which are the sites for assembly of HCV virions ([Figure 3](#fig3){ref-type="fig"}), and negatively regulate virus assembly without affecting viral replication ([@bib12]). YTDFH proteins interact with one m^6^A site in particular that is present within the envelope protein-encoding gene of HCV RNA. This site contains a DRA^m^CH motif that is a characteristic target for adenosine methylation. Mutational analysis of this site correlated with a 3-fold enhancement of HCV viral titer, without affecting viral replication or protein production ([@bib12]). This region of RNA containing the m^6^A motif has been shown to be bound by HCV Core protein to promote virion packaging and assembly ([@bib55]). Mutation of this site reduced YTHDF protein binding and enhanced HCV Core protein binding ([Figure 3](#fig3){ref-type="fig"}). Perhaps the role of YTHDF is antiviral, in which enhanced binding results in reduced nascent virion production, while Core binding prevents YTHDF binding, enhancing virion assembly within lipid droplets. It will be important to determine what signaling pathways activate METTL3/14-mediated methylation at distinct sites within the viral RNA genome to identify potential antiviral pathways that can be targeted for antiviral intervention.Figure 3The Role of Methyltransferases and Methyl Reader Proteins in Regulating the HCV Life CycleHCV RNA is modified at several adenosines (m^6^A) throughout the genome, and ablation of these modifications promotes viral replication and release from the cell. This process is modulated by YTHDF methyl readers sequestering m^6^A-modified HCV RNAs, preventing the localization and interaction with HCV Core protein at the lipid droplets and subsequent virus particle production. See text for further details.

Another member of the *Flaviviridae* family that has received recent attention by the scientific community is Zika virus. 2′-O-methyl modifications were abundant on adenosine, cytosine, and uracil ribonucleotides during Zika virus infection, while m^6^A was found to be present on strikingly 3% of all adenosines present within the ZV RNA genome ([@bib31]). Further, 12 m^6^A unique enrichment sites exist within the MR766 African strain of ZV, half of which are present in the region encoding the nonstructural protein, NS5, of the viral RNA and the 3′ UTR region ([@bib31]). Similarly to the role of m^6^A on regulating the HCV life cycle, writers METTL3 and METTL14 suppress replication, while erasers ALKBH5 and FTO enhance replication of ZV. Further, the methyl reader proteins YTHDF1--YTHDF3 bind m^6^A in ZV RNA, which correlates with viral RNA decay and reduced viral replication ([@bib31]). These data are corroborated by experiments demonstrating that the absence of METTL3/14 prevents YTHDF reader proteins from negatively regulating ZV replication ([@bib31]). Thus, m^6^A modifications within ZV negatively regulate the viral life cycle, similarly to HCV, albeit through different mechanisms.

To date, several studies have determined the host gene expression profiles in response to ZV infection ([@bib3], [@bib60], [@bib67]). ZV modulates the interferon response, cell cycle, protein localization, ER stress, and apoptosis in the infected host cell, among other pathways. Antiviral responses require fine-tuned regulation to optimally control viral infections without inducing immune-mediated pathology. RNA modifications in host cellular RNAs can play important roles during viral infection as described above. Indeed, ZV infection caused enrichment of m^6^A modifications of host mRNAs ([@bib31]). Because m^6^A acts at the post-transcriptional level to alter downstream pathways, it was not surprising that there was no significant change in the abundances of RNAs encoding antiviral proteins, including *IRF8*, *INFAR1*, *IFNAR2*, *MAP3K3*, and *IFIH1*, despite becoming enriched with m^6^A in response to ZV infection. Of course, it is likely that some of these genes are modulated at the post-transcriptional level. For example, m^6^A enhancement in 5′ UTRs of stress-induced host transcripts play a role in enhancing cap-independent translation of these mRNAs ([@bib69]). Indeed, members of the *Flaviviridae* virus family are known to modulate stress response pathways and the unfolded protein response ([@bib2], [@bib45], [@bib56]). Finally, YTHDF2 modulates the ability of FTO to remove m^6^A modifications in the 5′ UTR of heat shock-induced mRNAs by binding to these sites in the nucleus of heat shock-treated cells. Thus, it is possible that YTHDF binding to m^6^A sites within host and viral RNAs prevents host methyltransferases from modulating m^6^A enrichment. As a result, changes to mRNA stability and translation efficiency could occur in host mRNAs. In the case of ZV RNA, this effect seems to result in controlling ZV replication.

In addition to the importance of m^6^A modifications repressing the life cycle of the two members of the *Flaviviridae*, other family members have been observed to contain m^6^A sites within their RNA genomes. The m^6^A presence in WNV, DV, and YFV was recently reported, and unique, conserved sites for m^6^A modifications in NS3, NS5, and the 3′ UTR were discovered ([@bib12]). Notably, each of these mosquito-transmitted viruses contains secondary RNA structures that regulate viral translation and replication, many of which are within the 5′ and 3′ UTRs. Recent work determined that the 3′ UTR stem loop structures are important for viral replication and fitness with respect to mosquito-to-human transmission ([@bib63]). Perhaps the enrichment of m^6^A in human versus mosquito cells is modulated differently, leading to altered local RNA structures and RNA binding protein recruitment. For example, the methylation at putative sites located near the polypyrimidine-rich motif in the 3′ UTR may modulate RNA folding and the binding of hnRNP C, which is essential for HCV gene amplification ([@bib13]). Further studies will be important in identifying the differences between the methylomes of these viruses in different hosts to identify roles in viral pathogenesis.

Roles for N^6^,2-O-Dimethyladenosine Modification in the Viral Life Cycles {#sec1.3}
--------------------------------------------------------------------------

In addition to m^6^A, *N* ^6^,2-O-dimethyladenosine (m^6^A~m~) modification is abundant in cap structures, m^7^GpppN, present at the 5′ end of most viral and all host mRNAs ([Figure 1](#fig1){ref-type="fig"}; [@bib21], [@bib66]). This chemical modification was recently identified to play a role in regulating mRNA stability ([@bib37]). [@bib37] identified this novel cap-proximal modification within eukaryotic mRNAs containing adenosine as their first nucleotide. This modification is the preferential substrate for the eraser demethylase FTO, with a 100-fold greater catalytic efficiency toward m^6^A~m~ compared to the previously identified substrate, m^6^A. The preferential interaction between FTO and m^6^A~m~ was found to be due to the proximity of the adenosine to the RNA m^7^Gppp cap. Substitution of m^7^G with a non-methylated guanine reduced the rate of interaction ([@bib37]). Furthermore, the enzyme DCP2, which removes the m^7^Gppp cap on mRNAs, was shown to be the enzyme responsible for reading the m^6^A~m~ modification. Although no formal study has demonstrated a role for the METTL3/14 writer complex for m^6^A~m~ specifically, it is likely that this methyl-writer complex is responsible for the addition of this cap-specific moiety. This hypothesis is substantiated by the finding by Schwartz et al. that this process is WTAP-independent ([@bib54]). Interestingly, the presence of m^6^A~m~ in RNAs has distinct functions from the presence of m^6^A. m^6^A seems to play a role in enhancing mRNA decay, while the presence of m^6^A~m~ stabilizes RNA ([@bib37], [@bib59], [@bib64]). m^6^A~m~ modifications have been observed in influenza virus ([@bib25]) and herpes simplex virus type 1 ([@bib41]); however, the role of this modification in regulating the viral life cycles remains unexplored. It could be that m^6^A~m~ stabilizes viral RNA similarly to what is observed with host mRNAs, suggesting that viruses might utilize this modification to control the abundance of viral RNAs within the cell.

Roles for 2′-O-Methylation of Ribose Moieties in the Virus Life Cycle {#sec1.4}
---------------------------------------------------------------------

The 2′-O-me modification is a highly abundant chemical modification found on all types of eukaryotic RNAs. 2′-O-me-synthesized RNAs have been shown to act as agonists of the innate immune receptor Toll-like receptor 7 (TRL7), inhibiting the production of inflammatory cytokines, including type I interferon, in both mouse and human cells ([@bib51]). Thus, many siRNAs that are being used for gene manipulation contain modified bases at the 2′ ribose to prevent aberrant immune responses. Daffis et al. identified that members of the flaviviruses, poxviruses, and coronaviruses, all viruses that replicate in the cytoplasm, utilize a virus-encoded methyltransferase to add a 2′-O-methyl viral cap structure, resulting in the evasion from the antiviral activity exerted by murine *Ifit1* ([@bib7]), a member of the IFIT family that limits viral replication by binding to viral proteins and RNAs and regulating their functions. In human cells, IFIT5, but not IFIT1, IFIT2, or IFIT3, suppressed infection of a WNV mutant that lacks the ability to generate the 2′-O-me group without affecting the N^7^-methyltransferase activity of NS5 ([@bib50]). These findings suggest that cytoplasmic viruses containing the 2′-O-me RNA modification have enhanced virulence by evading the antiviral effects caused by distinct interferon-induced IFIT proteins. Interestingly, a number of IFIT family members attenuate translation ([@bib16], [@bib17], [@bib61]), suggesting that utilization of the 2′-O-me modulates viral pathogenicity.

In addition to immune evasion, 2′-O-me on viral RNAs prevents type I interferon production mediated by the dsRNA sensor MDA-5 during infection of cells with coronavirus family members ([@bib70]). Mutant human coronavirus lacking 2′-O-me enzymatic activity within non-structural protein Nsp16 enhanced expression of IFN-β in primary human macrophages compared to wild-type virus, suggesting that 2′-O-me has a biologically significant role in controlling the interferon response ([@bib70]). This process is dependent on MDA-5 because *mda5* knockout murine macrophages failed to produce detectable levels of IFN-β upon infection with a murine coronavirus, mouse hepatitis virus (MHV), which lacked enzymatic 2′-O-me function. In vivo infection models demonstrate that interferon signaling is a critical component of controlling MHV infection in the absence of 2′-O-me activity because interferon alpha/beta receptor (*Ifnar*) knockout mice rescued mutant virus spread and replication similar to wild-type MHV virus infection. Further, the growth of mutant and wild-type virus in *Mda5/Tlr7* double-knockout mice mirrored the levels observed in *Ifnar* knockout mice ([@bib70]), confirming that these sensors are critical in the detection of MHV, and that 2′-O-me serves as a virulence factor for this cytoplasmic virus. In contrast to the mechanism of IFIT-mediated restriction seen against WNV lacking 2′-O-me function, *Ifit1* knockout macrophages completely rescued MHV replication to wild-type virus levels, suggesting that this MDA-5-dependent IFN-β production is a distinct mechanism, because IFIT1 and IFIT2 overexpression failed to rescue mutant WNV replication ([@bib7]).

Roles for Adenosine to Inosine Modification in the Retroviral Life Cycle {#sec1.5}
------------------------------------------------------------------------

The significance of adenosine-to-inosine modifications (A-to-I editing) is appreciated for its abundance in both host and viral RNAs ([@bib52]). A-to-I editing is mediated by RNA adenosine deaminases (ADARs), which catalyze the deamination of carbon 6 to produce the inosine modification ([Figure 1](#fig1){ref-type="fig"}) within double-stranded RNA (dsRNA). A-to-I editing results in the destabilization of dsRNA structure through the inosine-uracil mismatch, which is less stable than the original adenosine-uracil pairing. Three ADARs exist, ADAR1, ADAR2, and ADAR3, all of which have been found to be sensitive to different cellular cues and whose expressions are cell specific. To date, the presence of inosines has been observed to modulate host-viral interactions in a number of viruses, including respiratory syncytial virus ([@bib29]) and HIV ([@bib9], [@bib47]).

Mutations in the ADAR genes have been linked to aberrant innate immune responses through the activation of the type I interferon signaling pathway by cytosolic sensors of endogenous host RNAs ([@bib32], [@bib36]). Using knockout animal models, the absence or mutation of ADAR1 was found to markedly enhance the expression of interferon-induced genes in the fetal liver, leading to heightened apoptosis and inflammation. Interestingly, A-to-I hyper-editing was identified in the 3′ UTR of a handful of specific genes. Based on in silico structural analysis, the substitution of adenosines with inosines inhibited perfect dsRNA stem loop structures, preventing the formation of long matched dsRNA ([@bib32]). These finds suggest that endogenous RNA lacking A-to-I editing can be recognized by cytosolic sensors, activating the innate immune response to double-stranded RNAs.

The role of A-to-I editing has been previously studied in HIV-infected human cell lines. Using siRNA knockdown and overexpression approaches, ADAR1 was found to correlate with reduced and enhanced expression of p24 Gag protein, respectively ([@bib9], [@bib47]). Importantly, the siRNA knockdown-mediated reduction in Gag protein expression could be rescued by an ADAR1 expression vector, suggesting that ADAR1 plays a positive role in regulating the life cycle of HIV in human cells. The importance of these observations is highlighted by the expression patterns of ADAR1 in primary human CD4^+^ T cells. Only in stimulated T cells did ADAR1 expression increase, while ADAR2 expression remained unchanged. Furthermore, the production of HIV is minimal in resting CD4^+^ T cells, suggesting a link between ADAR1 expression and HIV viral gene expression in activated CD4^+^ T cells. Alternative mechanisms, distinct from the RNA editing activity of ADAR1, have been suggested to contribute to HIV and vesicular stomatitis virus (VSV) life cycles ([@bib9], [@bib43]). Mutating the enzymatic region of ADAR1 enhanced HIV replication ([@bib9]). This observation was correlated with a reduction in phosphorylated PKR and eIF2α in cells transfected with the enzymatically silenced ADAR1 mutant, suggesting that a similar PKR-targeted mechanism might contribute to enhanced HIV replication, similar to what has been observed with VSV infection. The RNA-editing dependent and independent mechanisms may not be mutually exclusive, however. Finally, synthetic HIV constructs containing A-to-G mutations seem to be expressed more efficiently compared to wild-type HIV. However, there is no indication of whether such HIV isolates exist in nature. These A-to-I studies provide further examples of the importance of RNA modifications in regulating viral life cycles and immune response during infection.

Concluding Remarks {#sec1.6}
------------------

In this review, we have highlighted the recent advances in identifying the role for unique adenosine modifications in regulating the viral life cycle and the immune response to viral infection. There are some modifications we did not cover, such as m^5^C and pseudouridine, because there is insufficient information on their role in regulating viral RNAs or cellular antiviral responses. Curiously, some modifications, such as m^6^A, have both pro-viral and antiviral functions in distinct viral life cycles. Such opposite effects could be attributed to the intracellular localizations of viral RNAs, and thus availability of host proteins, that respond to m^6^A-modified RNAs. It is apparent that the field of viral epitranscriptomics is uncovering the importance of these RNA modifications at a rapid pace. Understanding how the dynamics of these modifications in viral and cellular RNAs affect distinct steps in the viral life cycles and viral pathogenesis will provide insight for the development of novel antiviral therapies.
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